BETA-LACTAMASE DETECTION DISCS

The contract calls for the procurement of 10 tubes of Beta-Lactamase Detection Discs, each containing 50 discs, under NSN 6550-01-300-8697, with delivery required within 20 days after award to the US Naval Hospital in Okinawa, Japan. The product must be stored and handled at refrigerated temperatures between 2°C and 8°C, and each unit must have a non-extendable shelf life of exactly 12 months, with no more than one month elapsed from the date of manufacture to the date of government delivery. Labeling must comply with Medical Marking Standard No. 1 (MMS No. 1), which supersedes MIL-STD-129, and must include the date of manufacture, expiration or retest date, and the contract number or lot number according to the latest revision of MMS1C. Packaging must meet commercial standards with sealed unit containers and protective exterior shipping containers suitable for export and safe transport at the lowest carrier rate, while also adhering to DLA’s packaging requirements and hazardous material labeling rules under OSHA and Federal Standard No. 313. All technical and quality specifications are governed by the DLA Master List of Technical and Quality Requirements identified under RA001, and the contractor must provide safety data sheets and update them if product composition changes. The item is subject to stringent safeguarding requirements for covered defense information, including compliance with NIST SP 800-171 and cybersecurity incident reporting via DFARS clause 252.204-7012. The contract obligates the contractor to use WAWF for electronic invoicing and receiving reports, and to ensure full compliance with federal laws regarding trafficking in persons, employment eligibility, sustainable products, and prohibition on certain defense telecommunications equipment. Additionally, the contractor must represent its small business status and disclose UEI and CAGE codes if supplying covered equipment or services, and is subject to oversight from the DLA Procuring Contracting Officer and buyer Seth Tootell, with all performance evaluated at destination by the government under FAR 52.246-2. This is a fixed-price solicitation issued through DIBBS with no pricing disclosed, and no options or extended terms are included.